Study Summary
This trial tests whether low-dose aspirin can reduce inflammation in postpartum patients with benign breast disease, which may prevent breast cancer.
- Breast Cancer
- Benign Breast Tumor
- Fibrocystic Breast Disease
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Pre- vs. post-intervention up to 30 days
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Prevention (low-dose aspirin)
1 of 1
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: Prevention (low-dose aspirin) · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 45 · Female Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many research participants are joining this clinical trial?
"That is correct. Based on the information available from clinicaltrials.gov, this study appears to be actively recruiting patients right now. 100 subjects are needed at a single location, and recruitment began on October 7th, 2020." - Anonymous Online Contributor
Are elderly patients eligible for this particular program?
"This particular trial is only for patients that fall in the age bracket of 18 to 45. However, there are a total of 65 studies involving minors and 2289 trials for senior citizens." - Anonymous Online Contributor
Is it harmful to take aspirin regularly as a preventative measure?
"Prevention (low-dose aspirin) is in Phase 2 of testing, meaning that while there is evidence suggesting it is safe, none yet supports its efficacy." - Anonymous Online Contributor
Are people with the specified medical conditions able to enroll in this clinical trial at this time?
"That is correct. The clinical trial was posted on 10/7/2022 and is actively recruiting 100 patients from 1 site, according to the most recent update on 10/10/2022." - Anonymous Online Contributor
Am I able to help with this research by enrolling in the trial?
"Eligibility criteria for this study includes being female and between 18-45 years old. The research team is looking to enroll around 100 individuals in total." - Anonymous Online Contributor